Recent

% | $
Quotes you view appear here for quick access.

Johnson & Johnson Message Board

code220s 24 posts  |  Last Activity: 21 hours ago Member since: Dec 16, 1997
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Go, MGEE, go!

    by eurafrules Feb 8, 2016 4:09 PM
    code220s code220s 21 hours ago Flag

    This stock is now way over valued at this price. Not DRIPing any new money into this stock at this price. I'll wait for a down turn or a stock split before I commit any new money to it. Still one of the best companies out there.

  • code220s by code220s Feb 2, 2016 3:32 PM Flag

    I think this stock is over valued at this point. I may be wrong. I am dollar-cost-averaging in now each month now. Waiting for a pull back to add very much more to it. Does anyone else have an opinion on it?

  • Reply to

    Key Reversal In

    by hughescliett1 Jan 14, 2016 8:52 AM
    code220s code220s Jan 28, 2016 9:02 AM Flag

    SPAM!!!!

  • code220s code220s Jan 28, 2016 8:59 AM Flag

    SPAM!!!!!!

  • Reply to

    Daytraders should check this out ASAP

    by risakjsaikiqpo6558 Jan 27, 2016 1:39 AM
    code220s code220s Jan 28, 2016 8:58 AM Flag

    SPAM!!!!!!

  • code220s code220s Jan 19, 2016 6:57 PM Flag

    Spam

  • Reply to

    MGE vs DUK

    by wnb1929 Jan 9, 2016 5:00 PM
    code220s code220s Jan 12, 2016 5:11 PM Flag

    As I Have said in some of the past posts, As of 18 December 2015 there is noting in the wind to suggest a merger or a take over. If one is to dollar-cost-average and reinvest the dividends. just sit back and enjoy the money. Keep on the look out for a pull back which would make a good entry point to commit a little bit more money than dollar-cost-averaging.

    Also, according to Valve Line, MGE earns good marks for Safety, Financial Strength, Price Stability, and Earnings Predictability. Volatility is below average with a beta of .75. The low price out between 2018-2020 is projected to be $45.00 and the high price for the same period to $50.00.

    Don't forget that must utility's stocks are what they call widow and orphan stocks. They will make you money over time. Dividends reinvesting and dollar-cost-averaging is investing, everything else is trading in my opinion.

    The capital of Wisconsin will always have some one turning on the lights.

  • code220s by code220s Jan 6, 2016 12:55 PM Flag

    I have been thinking about buying into this company through the direct buy and dividend reinvestment program. Can anybody make any suggestion if this is a good company to buy? I would be in it for the long haul. I would also be reinvesting my dividends into buying more stock.

  • Reply to

    Nice price on nice volume

    by eurafrules Dec 28, 2015 3:54 PM
    code220s code220s Jan 3, 2016 3:35 PM Flag

    As of 18 December 2015 there is noting in the wind to suggest a merger or a take over. If one is to dollar-cost-average and reinvest the dividends. just sit back and enjoy the money. Keep on the look out for a pull back which would make a good entry point to commit a little bit more money than dollar-cost-averaging.

    Also, according to Valveline, MGE earns good marks for Safety, Financial Strength, Price Stability, and Earnings Predictability. Volatility is below average with a beta of .75. The low price out between 2018-2020 is projected to be $45.00 and the high price for the same period to $50.00.

    Don't forget that must utility's stocks are what they call widow and orphan stocks. They will make you money over time. Dividends reinvesting and dollar-cost-averaging is investing, everything else is trading in my opinion.

    Sentiment: Buy

  • Reply to

    Dividend

    by gemini56292001 Dec 31, 2015 10:07 AM
    code220s code220s Dec 31, 2015 12:49 PM Flag

    Dividends for all four quarters have already paid. 07 Jan 2015, Mar 31 2015, Jun 30 2015, and Sept 30, 2015. When you get your next dividends, it will be some time in Jan of 2016. You will have to declare it on your taxes for 2016 tax year.

    Sentiment: Hold

  • Reply to

    dividend sustainability

    by noam1961 Nov 12, 2015 9:33 AM
    code220s code220s Dec 23, 2015 10:56 AM Flag

    Fstout57,
    Don't worry about the P/E of a REIT. Figure out what the P/FFO and the P/AFFO of any REITS that you are interested in. Merry Christmas and a Happy New Year. Also, happy investing.

  • Reply to

    Losing Hard?

    by byrannterrelhna Dec 18, 2015 10:06 AM
    code220s code220s Dec 19, 2015 10:15 AM Flag

    Quadruple, really? Your telling me this stock will go to $300.00 a share? What drugs are you taking?

  • code220s code220s Nov 24, 2015 5:15 PM Flag

    This tax code in this country is a mess. Its no wonder that companies are leaving this country and moving to a low tax country. Now this government wants to change the law about this merger. I have a better idea. Why don't they fix the tax codes?

    Sentiment: Buy

  • Reply to

    HCP Div Qualified

    by traderbbc Nov 19, 2015 8:38 PM
    code220s code220s Nov 23, 2015 10:11 AM Flag

    I am going to use distributions 2014 tax treatment of common stock dividends. The taxable ordinary dividend is $1.999208. Capital gains dividends are $0.089044. Nontaxable distribution is $0.091748 and total distribution paid is $2.18. You can fine this information on they web site. Go to investor relations, then to stock and dividend, then to dividend tax treatment. I hope this helps.

    Sentiment: Buy

  • code220s by code220s Nov 15, 2015 1:42 PM Flag

    It seems that most analyst say that the p/FFO is right around 11.4 11.4

    Sentiment: Buy

  • Reply to

    dividend

    by noam1961 Nov 7, 2015 11:31 AM
    code220s code220s Nov 9, 2015 1:03 PM Flag

    Better is use AFFO. Adjusted Funds From Operations (AFFO)
    This term refers to a computation made by analysts and investors to measure a real estate company's cash flow generated by operations. AFFO is usually calculated by subtracting from Funds from Operations (FFO) both (1) normalized recurring expenditures that are capitalized by the REIT and then amortized, but which are necessary to maintain a REIT's properties and its revenue stream (e.g., new carpeting and drapes in apartment units, leasing expenses and tenant improvement allowances) and (2) "straight-lining" of rents. This calculation also is called Cash Available for Distribution (CAD) or Funds Available for Distribution (FAD).

  • Been looking at this stock for some time now. Would like an opinion if this stock would be good for a stock re-investment program? In general, is this stock a good company? The yield seems good. Help. I see it in different investment news letters and news paper all the time. Thank you for your help.

  • code220s by code220s Oct 17, 2015 9:04 AM Flag

    I got this off Stock Investor news letter. Makes for some interesting reading.

    We are holding steady to our $99 fair value estimate for Johnson & Johnson following third-quarter results that fell slightly below our top-line expectations but largely matched our earnings projections. Excluding acquisitions and divestitures, J&J posted operational sales growth of 1% year over year led by the consumer group, as lost hepatitis C drug sales created a 500-basis-point headwind in the quarter. On the 8% bottom-line decline, other one-time gains helped mitigate the lost high-margin hepatitis C drug sales. In total, the steady third-quarter results reaffirm our wide moat rating based on a developing late-stage pipeline and strong brand power across the medical device and consumer groups. The announced $10 billion open-ended share-repurchase program appears to be a good use of capital with the stock price trading below our fair value estimate. However, we still expect J&J to make a meaningful acquisition to help accelerate its tepid long-term growth rate.

    As the largest operating segment, the drug group (45% of total sales) posted 10% operational growth year over year, excluding the lost hepatitis C sales. With our projections for hepatitis C drug sales representing only 1% of total 2015 revenue, this headwind should dissipate in 2016. Further, several recently launched drugs, including diabetes drug Invokana and cardiovascular drug Xarelto, are early in their life cycles and should support robust growth in 2016, which should help give J&J time to develop its late-stage pipeline.

    The consumer segment (up 4%) benefited from the relaunch of several products previously hurt by manufacturing issues, while a global slowdown in healthcare demand weighed on the device group (up 1%). Over next three years, we expect both divisions to post steady 3% annualized growth as brand power remains strong and innovation should improve in the device space with surgical tools and robotics.

    Sentiment: Hold

  • code220s by code220s Oct 16, 2015 4:09 PM Flag

    I have been thinking about investing in this company. I would also like to get into the dividend reinvestment program. I would like some opinions about this company. I would be investing for the long term. Would this be a good company to invest in? How long have other people been invested in the company?

  • code220s by code220s Oct 12, 2015 5:43 PM Flag

    Been thinking about buying into this stock. Buy the first share through a broker and then get into the dividend reinvestment program. Would this be a good income investment? I am looking for a long term investment. Some of you people have owned the stock for a long time, are you happy with it? Please help a potential investor.

JNJ
101.97-0.03(-0.03%)Feb 9 4:01 PMEST